methylnitrosourea has been researched along with tamoxifen in 67 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 19 (28.36) | 18.7374 |
1990's | 27 (40.30) | 18.2507 |
2000's | 11 (16.42) | 29.6817 |
2010's | 9 (13.43) | 24.3611 |
2020's | 1 (1.49) | 2.80 |
Authors | Studies |
---|---|
Ebert, K; Knuppen, R; Michna, H; Vollmer, G | 1 |
Arnold, W; Fichtner, I; Görlich, M; Hauff, P; Staab, HJ; Winterfeld, G | 2 |
Crowe, JP; Osborne, MP; Rosen, PP; Ruperto, JF; Telang, NT | 1 |
Blask, DE; Grosso, DS; Hill, SM; Lemus-Wilson, A; Pelletier, DB; Wilson, ST; Wise, ME | 1 |
Chander, SK; Coombes, RC; Dowsett, M; Jarman, M; Luqmani, Y; McCague, R; Newton, C | 1 |
Baluch, S; Coombes, RC; Griffiths, JR; Midwood, CJ; Stubbs, M | 1 |
Detrisac, CJ; Dinger, NM; Kelloff, GJ; Moon, RC; Ratko, TA; Thomas, CF | 1 |
Dinger, NM; Dowlatshahi, K; Mehta, RG; Moon, RC; Thomas, CF | 1 |
McCormick, DL; Moon, RC | 1 |
Meeker, LD; Ritacco, KA; Ronan, AM; Thompson, HJ | 1 |
Ronan, AM; Thompson, HJ | 1 |
Badger, TM; Jay, JR; MacLaughlin, DT; Martuza, RL; Miller, DC | 1 |
Alvarez, E; Calaf, G; Jordan, C; Ramírez, G; Rodríguez, R | 1 |
Gottardis, MM; Jordan, VC | 1 |
Coombes, RC; Easton, D; Goss, PE; Singh, D; Wilkinson, JR; Williams, JC | 1 |
Demers, L; Luk, G; Manni, A; Wright, C | 1 |
Berger, M; Prekajac, J; von Angerer, E | 1 |
Manni, A; Pontari, M; Wright, C | 1 |
Arafah, BM; Finegan, HM; Manni, A; Pearson, OH; Rainieri, J | 1 |
Manni, A; Wright, C | 1 |
Irigoyen, ML; Nardi, J; Sarría, JA; Sosa, R | 1 |
Arafah, BM; Gordon, NH; Pearson, OH; Wilhite, BL | 1 |
Fiebig, HH; Schmähl, D | 1 |
Fischer, AH; Jordan, VC; Rose, DP | 1 |
Bryan, GT; Ertürk, E; Pruitt, B; Rose, DP; Stauber, P | 1 |
Archer, MC; Chaulk, JE; Hu, Z; Lu, SJ; Xu, Z | 1 |
Anver, MR; Anzano, MA; Brown, CC; Driver, CL; Green, DM; Logsdon, DL; Lucia, MS; Peer, CW; Shrader, MW; Slayter, MV | 1 |
Anzano, MA; Brown, CC; Byers, SW; Mullen, LT; Peer, CW; Roberts, AB; Smith, JM; Sporn, MB | 1 |
Anzano, MA; Driver, CL; Letterio, JJ; Logsdon, DL; Mullen, LT; Peer, CW; Shrader, MW; Smith, JM; Uskoković, MR; Welsh, MC | 1 |
Furmanski, P; Kantorowitz, DA; Thompson, HJ | 1 |
Fujimoto, N; Gotoh, T; Ito, A; Okamoto, T | 1 |
Borges, A; Kothari, A; Kothari, L | 1 |
Andrade, N; Bergoc, R; Caro, R; Cricco, G; Davio, C; Levin, E; Martin, G; Melito, G; Rivera, E | 1 |
Bowman-Gram, TA; Johnson, WD; Kellof, GJ; Lubet, RA; McCormick, DL; Rao, KV; Steele, VE | 1 |
Chander, SK; Coombes, RC; Evans, TR; Luqmani, YA; Rowlands, MG | 1 |
Borges, A; Ingle, A; Kothari, A; Kothari, L | 1 |
Andrade, N; Bergoc, R; Caro, R; Cricco, G; Davio, C; Martin, G; Melito, G; Rivera, E | 1 |
Mazurik, VK; Nikhaĭlov, VF; Raeva, NF; Ushenkova, LN | 1 |
Bliss, J; Coombes, RC; Hewer, A; Jarman, M; Pace, P; Phillips, D | 1 |
Bischoff, ED; Gottardis, MM; Heyman, RA; Lamph, WW; Moon, TE | 1 |
Dohi, K; Gotoh, T; Ito, A; Kataoka, T; Yamada, K; Yin, H | 1 |
Fujimoto, J; Hashimoto, M; Itoh, T; Mori, H; Morishita, S; Niwa, K; Tamaya, T | 1 |
Bergoc, RM; Cocca, C; Cricco, G; Croci, M; Davio, C; Fitzsimons, C; Gutierrez, A; Lemos, B; Levin, E; Levin, R; Martin, G; Rivera, E | 1 |
Gilmer, T; Risingsong, R; Sporn, MB; Suh, N; Wang, Y; Williams, CR; Willson, TM | 1 |
Bischoff, ED; Heyman, RA; Lamph, WW | 1 |
Adámeková, E; Ahlers, I; Ahlersová, E; Bojková, B; Cermáková, M; Kubatka, P; M ciková-Kalická, K; Mníchová-Chamilová, M | 1 |
Aliaga, C; Cohen, LA; Moyer, JD; Pittman, B; Wang, CX; Yu, L | 1 |
Christov, K; Green, A; Grubbs, C; Ikui, A; Lubet, R; Shilkaitis, A; Steele, V; Weinstein, IB; Yao, R; You, M | 1 |
Atigadda, VR; Beenken, SW; Bland, KI; Brouillette, WJ; Eto, I; Grubbs, CJ; Hill, DL; Lin, TH; Muccio, DD; Vines, KK | 1 |
Guzman, RC; Nandi, S; Rajkumar, L; Talamantes, F; Thordarson, G; Yang, J | 1 |
Bohlmann, R; Gieschen, H; Heinrich, N; Hoffmann, J; Hofmeister, H; Kroll, J; Künzer, H; Lichtner, RB; Nishino, Y; Parczyk, K; Sauer, G; Schneider, MR; Ulbrich, HF | 1 |
Christov, K; Eto, I; Grubbs, CJ; Hursting, SD; Juliana, MM; Lubet, RA; Nunez, NP; Steele, VE | 1 |
Bergoc, R; Cocca, C; Crescenti, E; Cricco, G; Croci, M; Gutiérrez, A; Martín, G; Medina, V; Mohamad, N; Núñez, M; Rivera, E | 1 |
Goss, PE; Hu, H; Qi, S; Strasser-Weippl, K | 1 |
Akinaga, S; Anazawa, H; Ishida, H; Kuwabara, T; Li, PK; Murakata, C; Nakata, T; Sato, N; Shiotsu, Y; Suzuki, M; Takebayashi, M; Tanaka, H; Terasaki, Y | 1 |
Boring, D; Grubbs, CJ; Juliana, MM; Lubet, RA; Ruppert, JM; Steele, VE | 1 |
Aliaga, C; Bruggeman, R; Calcagnotto, A; Cooper, T; El-Bayoumy, K; Manni, A; Mauger, D; Prokopczyk, B; Richie, JP; Trushin, N; Verderame, MF; Washington, S; Xu, H | 1 |
El Bayoumy, K; Jiang, W; Manni, A; McGinley, JN; Prokopczyk, B; Richie, JP; Thompson, HJ; Zhu, Z | 1 |
Aliaga, C; Bruggeman, R; Calcagnotto, A; Cooper, TK; Das, A; Dickinson, R; El-Bayoumy, K; Liao, J; Manni, A; Prokopczyk, B; Richie, JP; Trushin, N; Verderame, MF; Washington, S; Xu, H | 1 |
Aliaga, C; Bidinotto, LT; de Cicco, RL; El-Bayoumy, K; Manni, A; Russo, IH; Russo, J; Santucci-Pereira, J; Vanden Heuvel, JP; Vanegas, JE; Washington, S; Xu, H | 1 |
Bortner, JD; Das, A; El-Bayoumy, K; Manni, A; Skibinski, CG; Stanley, A; Stanley, BA; Thompson, HJ | 1 |
Aliaga, C; Bruggeman, R; Calcagnotto, A; Cooper, TK; Das, A; El-Bayoumy, K; Liao, J; Manni, A; Prokopczyk, B; Richie, JP; Trushin, N; Washington, S; Xu, H | 1 |
Emilia, ST; Shaari, R; Yaacob, NS; Yankuzo, HM | 1 |
Baretton, GB; Goerl, F; Louw, A; Macejová, D; Muders, M; Visser, K; Vollmer, G; Zierau, O | 1 |
Clark-Knowles, KV; Coulombe, J; Daneshmand, M; Dewar-Darch, D; He, X; Jardine, KE; McBurney, MW | 1 |
Ansari, MN; Choudhary, A; Kaithwas, G; Kumar, D; Raj, R; Rastogi, S; Saeedan, AS; Singh, L; Singh, M | 1 |
2 review(s) available for methylnitrosourea and tamoxifen
Article | Year |
---|---|
[A study model of estrogens and antiestrogens analysis].
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Binding Sites; Estrogen Antagonists; Estrogens; Female; Humans; Mammary Neoplasms, Experimental; Methylnitrosourea; Mice; Neoplasm Transplantation; Rats; Tamoxifen | 1987 |
Endocrine and cytostatic treatment of experimental mammary cancer.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Antineoplastic Agents; Carmustine; Castration; Cyclophosphamide; Doxorubicin; Drug Therapy, Combination; Ergolines; Female; Fluorouracil; Mammary Neoplasms, Experimental; Methotrexate; Methylnitrosourea; Mice; Nitrosourea Compounds; Prednisolone; Rats; Tamoxifen; Vincristine | 1980 |
65 other study(ies) available for methylnitrosourea and tamoxifen
Article | Year |
---|---|
Down-regulation of tenascin expression by antiprogestins during terminal differentiation of rat mammary tumors.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Cell Adhesion Molecules, Neuronal; Cell Differentiation; Extracellular Matrix Proteins; Female; Gonanes; Immunohistochemistry; Mammary Neoplasms, Experimental; Methylnitrosourea; Ovariectomy; Progesterone; Rats; Tamoxifen; Tenascin; Uterus | 1992 |
Investigations of droloxifene and other hormone manipulations on N-nitrosomethylurea-induced rat mammary tumours. 1. Influence on tumour growth.
Topics: Animals; Antineoplastic Agents; Body Weight; Estrogen Antagonists; Female; Mammary Neoplasms, Experimental; Methylnitrosourea; Ovariectomy; Rats; Rats, Sprague-Dawley; Tamoxifen | 1992 |
Investigations of droloxifene and other hormonal manipulations on N-nitrosomethylurea-induced rat mammary tumours. 2. Influence on oestrogen receptor.
Topics: Aminoglutethimide; Animals; Antineoplastic Agents; Estradiol; Estrogen Antagonists; Female; Mammary Neoplasms, Experimental; Methylnitrosourea; Ovariectomy; Rats; Receptors, Estrogen; Tamoxifen | 1992 |
Effect of tamoxifen on preneoplastic cell proliferation in N-nitroso-N-methylurea-induced mammary carcinogenesis.
Topics: Animals; Cell Division; Female; Mammary Glands, Animal; Mammary Neoplasms, Experimental; Methylnitrosourea; Precancerous Conditions; Rats; Rats, Inbred Strains; Tamoxifen | 1992 |
Pineal melatonin inhibition of tumor promotion in the N-nitroso-N-methylurea model of mammary carcinogenesis: potential involvement of antiestrogenic mechanisms in vivo.
Topics: Animals; Disease Models, Animal; Estradiol; Female; Mammary Neoplasms, Experimental; Melatonin; Methylnitrosourea; Mice; Neoplasm Recurrence, Local; Ovariectomy; Pineal Gland; Prolactin; Radioimmunoassay; Receptors, Estrogen; Tamoxifen | 1991 |
Pyrrolidino-4-iodotamoxifen and 4-iodotamoxifen, new analogues of the antiestrogen tamoxifen for the treatment of breast cancer.
Topics: Animals; Breast Neoplasms; Cell Division; Cell Line; Drug Screening Assays, Antitumor; Estradiol Congeners; Female; Humans; Mammary Neoplasms, Experimental; Methylnitrosourea; Rats; Rats, Inbred Strains; Receptors, Estrogen; Tamoxifen | 1991 |
Monitoring therapeutic response to tamoxifen in NMU-induced rat mammary tumours by 31P MRS.
Topics: Animals; Female; Magnetic Resonance Spectroscopy; Mammary Neoplasms, Experimental; Methylnitrosourea; Nucleotides; Phosphates; Phosphorus; Rats; Rats, Inbred Strains; Tamoxifen | 1991 |
Chemopreventive efficacy of combined retinoid and tamoxifen treatment following surgical excision of a primary mammary cancer in female rats.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Drug Evaluation, Preclinical; Female; Fenretinide; Mammary Neoplasms, Experimental; Methylnitrosourea; Rats; Rats, Inbred Strains; Tamoxifen; Tretinoin | 1989 |
Therapeutic effect of N-(4-hydroxyphenyl)retinamide on N-methyl-N-nitrosourea-induced rat mammary cancer.
Topics: Adenocarcinoma; Animals; Antineoplastic Combined Chemotherapy Protocols; Female; Fenretinide; Mammary Neoplasms, Experimental; Methylnitrosourea; Rats; Remission Induction; Tamoxifen; Tretinoin | 1989 |
Retinoid-tamoxifen interaction in mammary cancer chemoprevention.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Body Weight; Dose-Response Relationship, Drug; Drug Synergism; Female; Fenretinide; Mammary Neoplasms, Experimental; Methylnitrosourea; Mice; Ovariectomy; Rats; Rats, Inbred Strains; Tamoxifen; Tretinoin | 1986 |
Effect of tamoxifen and D,L-2-difluoromethylornithine on the growth, ornithine decarboxylase activity and polyamine content of mammary carcinomas induced by 1-methyl-1-nitrosourea.
Topics: Animals; Eflornithine; Female; Mammary Neoplasms, Experimental; Methylnitrosourea; Ornithine; Ornithine Decarboxylase; Polyamines; Rats; Rats, Inbred Strains; Tamoxifen | 1986 |
Effect of D,L-2-difluoromethylornithine and endocrine manipulation on the induction of mammary carcinogenesis by 1-methyl-1-nitrosourea.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Dose-Response Relationship, Drug; Eflornithine; Female; Mammary Neoplasms, Experimental; Methylnitrosourea; Ovariectomy; Polyamines; Rats; Rats, Inbred Strains; Tamoxifen | 1986 |
Hormonal modulation of Schwann cell tumors. I. The effects of estradiol and tamoxifen on methylnitrosourea-induced rat Schwann cell tumors.
Topics: Animals; Estradiol; Male; Methylnitrosourea; Nervous System Neoplasms; Neurofibromatosis 1; Rats; Rats, Inbred Strains; Receptors, Estrogen; Receptors, Progesterone; Schwann Cells; Tamoxifen | 1986 |
Antitumor actions of keoxifene and tamoxifen in the N-nitrosomethylurea-induced rat mammary carcinoma model.
Topics: Animals; Dose-Response Relationship, Drug; Estrogen Antagonists; Female; Mammary Neoplasms, Experimental; Methylnitrosourea; Neoplasms, Hormone-Dependent; Organ Size; Ovariectomy; Piperidines; Raloxifene Hydrochloride; Rats; Rats, Inbred Strains; Receptors, Estrogen; Tamoxifen; Time Factors; Uterus | 1987 |
Response of nitrosomethylurea-induced rat mammary tumor to endocrine therapy and comparison with clinical response.
Topics: Aminoglutethimide; Androstenedione; Animals; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Danazol; Dihydrotestosterone; Female; Humans; Mammary Neoplasms, Experimental; Menopause; Methylnitrosourea; Ovariectomy; Rats; Tamoxifen | 1986 |
Polyamines and hormonal regulation of N-nitrosomethylurea-induced rat mammary tumor growth in vivo.
Topics: Animals; Estrogens; Female; Mammary Neoplasms, Experimental; Methylnitrosourea; Ovariectomy; Polyamines; Putrescine; Rats; Rats, Inbred Strains; Receptors, Estrogen; Receptors, Progesterone; Tamoxifen | 1986 |
The inhibitory effect of 5-acetoxy-2-(4-acetoxyphenyl)-1-ethyl-3-methylindole (D 16726) on estrogen-dependent mammary tumors.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Breast Neoplasms; Female; Humans; Indoles; Mammary Neoplasms, Experimental; Methylnitrosourea; Mice; Mice, Inbred Strains; Neoplasm Transplantation; Neoplasms, Hormone-Dependent; Rats; Rats, Inbred Strains; Receptors, Estrogen; Tamoxifen | 1985 |
Polyamines and estrogen control of growth of the NMU-induced rat mammary tumor.
Topics: Animals; Body Weight; Cell Division; Dose-Response Relationship, Drug; Drug Interactions; Eflornithine; Estradiol; Estrogens; Female; Mammary Neoplasms, Experimental; Methylnitrosourea; Mitoguazone; Nitrosourea Compounds; Ornithine; Ornithine Decarboxylase; Polyamines; Rats; Rats, Inbred Strains; Tamoxifen | 1985 |
Role of estrogen and prolactin in the growth and receptor levels of N-nitrosomethylurea-induced rat mammary tumors.
Topics: Animals; Bromocriptine; Castration; Estradiol; Female; Mammary Neoplasms, Experimental; Methylnitrosourea; Perphenazine; Prolactin; Rats; Receptors, Cell Surface; Receptors, Estrogen; Receptors, Prolactin; Tamoxifen | 1982 |
Effect of tamoxifen and alpha-difluoromethylornithine on clones of nitrosomethylurea-induced rat mammary tumor cells grown in soft agar culture.
Topics: Agar; Animals; Cells, Cultured; Clone Cells; Dose-Response Relationship, Drug; Eflornithine; Female; Mammary Neoplasms, Experimental; Methylnitrosourea; Nitrosourea Compounds; Ornithine; Rats; Rats, Inbred Strains; Tamoxifen | 1983 |
[Tamoxifen as a suppressor of mammary carcinogenesis induced by 7,12-dimethyl-benzanthracene and methylnitrosourea, in female rats with induced hyperprolactinemia].
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Breast Neoplasms; Female; Methylnitrosourea; Nitrosourea Compounds; Prolactin; Rats; Sulpiride; Tamoxifen | 1983 |
Influence of estradiol and tamoxifen on the growth of N-nitrosomethylurea-induced rat mammary tumor cells in soft agar.
Topics: Agar; Animals; Cell Division; Cell Survival; Cells, Cultured; Drug Antagonism; Estradiol; Female; Mammary Neoplasms, Experimental; Methylnitrosourea; Rats; Rats, Inbred Strains; Tamoxifen | 1984 |
Activity of the antioestrogen trioxifene against N-Nitrosomethylurea-induced rat mammary carcinomas.
Topics: Animals; Antineoplastic Agents; Castration; Estradiol; Estrogen Antagonists; Female; Mammary Neoplasms, Experimental; Methylnitrosourea; Pyrrolidines; Rats; Rats, Inbred Strains; Receptors, Estrogen; Tamoxifen | 1981 |
Influence of dosage schedule on the biological characteristics of N-nitrosomethylurea-induced rat mammary tumors.
Topics: Animals; Castration; Female; Mammary Neoplasms, Experimental; Methylnitrosourea; Nitrosourea Compounds; Rats; Receptors, Estrogen; Remission, Spontaneous; Tamoxifen; Time Factors | 1980 |
Effect of dietary fat or tamoxifen on the expansion of cells harboring Ha-ras oncogenes in mammary glands from methylnitrosourea-treated rats.
Topics: Animals; Antineoplastic Agents, Hormonal; Carcinogens; Cell Division; Dietary Fats; Female; Genes, ras; Mammary Glands, Animal; Methylnitrosourea; Mutation; Polymerase Chain Reaction; Rats; Tamoxifen | 1995 |
Chemopreventive activity of tamoxifen, N-(4-hydroxyphenyl)retinamide, and the vitamin D analogue Ro24-5531 for androgen-promoted carcinomas of the rat seminal vesicle and prostate.
Topics: Androgens; Animals; Anticarcinogenic Agents; Calcitriol; Carcinogens; Drug Screening Assays, Antitumor; Male; Methylnitrosourea; Neoplasms, Experimental; Neoplasms, Hormone-Dependent; Prostate; Prostatic Neoplasms; Rats; Seminal Vesicles; Tamoxifen; Testosterone | 1995 |
Prevention of breast cancer in the rat with 9-cis-retinoic acid as a single agent and in combination with tamoxifen.
Topics: Animals; Breast Neoplasms; Drug Screening Assays, Antitumor; Humans; Mammary Neoplasms, Experimental; Methylnitrosourea; Rats; Rats, Sprague-Dawley; Tamoxifen; Tretinoin; Tumor Cells, Cultured | 1994 |
1 alpha,25-Dihydroxy-16-ene-23-yne-26,27-hexafluorocholecalciferol (Ro24-5531), a new deltanoid (vitamin D analogue) for prevention of breast cancer in the rat.
Topics: Adenocarcinoma; Animals; Anticarcinogenic Agents; Breast Neoplasms; Calcitriol; Calcium; Cell Division; Cell Line; Diet; Female; Humans; Mammary Neoplasms, Experimental; Methylnitrosourea; Neoplasm Invasiveness; Rats; Rats, Sprague-Dawley; Tamoxifen; Tumor Cells, Cultured | 1994 |
Effect of conjoint administration of tamoxifen and high-dose radiation on the development of mammary carcinoma.
Topics: Animals; Chemotherapy, Adjuvant; Combined Modality Therapy; Female; Injections, Subcutaneous; Mammary Neoplasms, Experimental; Methylnitrosourea; Rats; Rats, Sprague-Dawley; Tamoxifen | 1993 |
Effect of retinoic acid (RA) in MNU-induced rat mammary tumors.
Topics: Animals; Anticarcinogenic Agents; Carcinogens; Estradiol; Female; Mammary Neoplasms, Experimental; Methylnitrosourea; Ovariectomy; Rats; Rats, Sprague-Dawley; Tamoxifen; Tretinoin | 1995 |
Chemoprevention by melatonin and combined melatonin-tamoxifen therapy of second generation nitroso-methylurea-induced mammary tumours in rats.
Topics: Animals; Anticarcinogenic Agents; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Carcinogens; Chemoprevention; Chemotherapy, Adjuvant; Disease-Free Survival; Drug Synergism; Estrogen Antagonists; Female; Mammary Neoplasms, Animal; Melatonin; Methylnitrosourea; Neoplasms, Second Primary; Pharmaceutical Vehicles; Rats; Rats, Sprague-Dawley; Tamoxifen | 1995 |
Effect of tamoxifen on intraperitoneal N-nitroso-N-methylurea induced tumors.
Topics: Animals; Antineoplastic Agents, Hormonal; Carcinogens; Estrogen Antagonists; Female; Injections, Intraperitoneal; Mammary Neoplasms, Experimental; Methylnitrosourea; Rats; Rats, Sprague-Dawley; Receptors, Estrogen; Tamoxifen | 1996 |
Exceptional chemopreventive activity of low-dose dehydroepiandrosterone in the rat mammary gland.
Topics: Animals; Anticarcinogenic Agents; Carbenoxolone; Carcinogens; Dehydroepiandrosterone; Diet; Drug Administration Schedule; Female; Mammary Neoplasms, Experimental; Methylnitrosourea; Rats; Rats, Sprague-Dawley; Tamoxifen | 1996 |
Detection of breast cancer-associated estrone sulfatase in breast cancer biopsies and cell lines using polymerase chain reaction.
Topics: Animals; Antineoplastic Agents, Hormonal; Base Sequence; Biopsy; Blotting, Northern; Breast Neoplasms; Carcinogens; DNA Primers; DNA, Complementary; Female; Humans; Mammary Neoplasms, Experimental; Methylnitrosourea; Molecular Sequence Data; Polymerase Chain Reaction; Rats; RNA, Neoplasm; Sulfatases; Tamoxifen; Tumor Cells, Cultured | 1993 |
Combination of melatonin and tamoxifen as a chemoprophylaxis against N-nitroso-N-methylurea-induced rat mammary tumors.
Topics: Animals; Anticarcinogenic Agents; Body Weight; Carcinogens; Female; Mammary Glands, Animal; Mammary Neoplasms, Experimental; Melatonin; Methylnitrosourea; Rats; Rats, Sprague-Dawley; Tamoxifen | 1997 |
Hormone dependence of mammary tumors induced in rats by intraperitoneal NMU injection.
Topics: Animals; Bromocriptine; Carcinogens; Estradiol; Female; Haloperidol; Injections, Intraperitoneal; Mammary Neoplasms, Experimental; Methylnitrosourea; Neoplasms, Hormone-Dependent; Ovariectomy; Progesterone; Prolactin; Rats; Rats, Sprague-Dawley; Tamoxifen | 1997 |
[DNA repair and O(-)2-generating system of nonspecific defense during induced radioresistance].
Topics: Animals; Cells, Cultured; DNA Repair; Dogs; Humans; Methylnitrosourea; Mice; Mice, Inbred BALB C; Mutagens; Radiation Tolerance; Radiation-Sensitizing Agents; Superoxides; Tamoxifen | 1997 |
Idoxifene is equipotent to tamoxifen in inhibiting mammary carcinogenesis but forms lower levels of hepatic DNA adducts.
Topics: Animals; DNA Adducts; Female; Liver; Mammary Neoplasms, Experimental; Methylnitrosourea; Rats; Survival Analysis; Tamoxifen; Time Factors | 1997 |
Beyond tamoxifen: the retinoid X receptor-selective ligand LGD1069 (TARGRETIN) causes complete regression of mammary carcinoma.
Topics: Animals; Anticarcinogenic Agents; Antineoplastic Agents; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Bexarotene; Cell Division; Drug Screening Assays, Antitumor; Drug Synergism; Female; Mammary Neoplasms, Experimental; Methylnitrosourea; Rats; Rats, Sprague-Dawley; Receptors, Retinoic Acid; Retinoid X Receptors; Tamoxifen; Tetrahydronaphthalenes; Transcription Factors | 1998 |
Chemoprevention of N-nitroso-N-methylurea-induced rat mammary cancer by miso and tamoxifen, alone and in combination.
Topics: Animals; Body Weight; Drug Therapy, Combination; Female; Glycine max; Mammary Neoplasms, Experimental; Methylnitrosourea; Rats; Rats, Sprague-Dawley; Tamoxifen; Time Factors | 1998 |
Effects of tamoxifen on endometrial carcinogenesis in mice.
Topics: Adenocarcinoma; Animals; Carcinogens; Cocarcinogenesis; Endometrial Neoplasms; Endometrium; Estradiol; Female; Hyperplasia; Methylnitrosourea; Mice; Mice, Inbred ICR; Ovariectomy; Polymerase Chain Reaction; Proto-Oncogene Proteins c-fos; Proto-Oncogene Proteins c-jun; RNA, Messenger; Tamoxifen | 1998 |
An experimental model of diabetes and cancer in rats.
Topics: Animals; Anti-Bacterial Agents; Anticarcinogenic Agents; Carcinogens; Cell Division; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Female; Insulin; Mammary Neoplasms, Experimental; Methylnitrosourea; Rats; Streptozocin; Tamoxifen | 1998 |
A new ligand for the peroxisome proliferator-activated receptor-gamma (PPAR-gamma), GW7845, inhibits rat mammary carcinogenesis.
Topics: Animals; Anticarcinogenic Agents; Carcinogens; Drug Screening Assays, Antitumor; Female; Ligands; Mammary Neoplasms, Experimental; Methylnitrosourea; Oxazoles; Rats; Rats, Sprague-Dawley; Receptors, Cytoplasmic and Nuclear; Tamoxifen; Transcription Factors; Tyrosine | 1999 |
Effect of the retinoid X receptor-selective ligand LGD1069 on mammary carcinoma after tamoxifen failure.
Topics: Animals; Anticarcinogenic Agents; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Bexarotene; Carcinogens; Disease Progression; Female; Mammary Neoplasms, Experimental; Methylnitrosourea; Rats; Rats, Sprague-Dawley; Tamoxifen; Tetrahydronaphthalenes; Treatment Failure; Treatment Outcome | 1999 |
Effects of tamoxifen and melatonin on mammary gland cancer induced by N-methyl-N-nitrosourea and by 7,12-dimethylbenz(a)anthracene, respectively, in female Sprague-Dawley rats.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Carcinogens; Estrogen Receptor Modulators; Female; Mammary Neoplasms, Experimental; Melatonin; Methylnitrosourea; Rats; Rats, Sprague-Dawley; Tamoxifen | 2001 |
LAS, a novel selective estrogen receptor modulator with chemopreventive and therapeutic activity in the N-nitroso-N-methylurea-induced rat mammary tumor model.
Topics: Animals; Anticarcinogenic Agents; Antineoplastic Agents; Carcinogens; Estrogen Antagonists; Female; Mammary Neoplasms, Experimental; Methylnitrosourea; Pyrrolidines; Rats; Rats, Sprague-Dawley; Selective Estrogen Receptor Modulators; Tamoxifen; Tetrahydronaphthalenes; Weight Gain | 2001 |
Cell proliferation, apoptosis, and expression of cyclin D1 and cyclin E as potential biomarkers in tamoxifen-treated mammary tumors.
Topics: Animals; Biomarkers, Tumor; Blotting, Western; Cell Division; Cyclin D1; Cyclin E; Female; Mammary Neoplasms, Experimental; Methylnitrosourea; Neoplasms, Hormone-Dependent; Rats; Rats, Sprague-Dawley; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Selective Estrogen Receptor Modulators; Tamoxifen; Tumor Cells, Cultured | 2003 |
9cUAB30, an RXR specific retinoid, and/or tamoxifen in the prevention of methylnitrosourea-induced mammary cancers.
Topics: Administration, Oral; Alkylating Agents; Animals; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Body Weight; Chromatography, High Pressure Liquid; Diet; Dose-Response Relationship, Drug; Fatty Acids, Unsaturated; Female; Mammary Neoplasms, Experimental; Methylnitrosourea; Naphthalenes; Rats; Rats, Sprague-Dawley; Receptors, Retinoic Acid; Retinoid X Receptors; Retinoids; Tamoxifen; Transcription Factors | 2003 |
Prevention of mammary carcinogenesis by short-term estrogen and progestin treatments.
Topics: 2-Methoxyestradiol; Alkylating Agents; Animals; Antineoplastic Combined Chemotherapy Protocols; Estradiol; Estriol; Estrogens; Ethinyl Estradiol; Female; Mammary Neoplasms, Animal; Megestrol Acetate; Methylnitrosourea; Norethindrone; Progesterone; Progestins; Rats; Rats, Inbred Lew; Tamoxifen; Time Factors; Treatment Outcome | 2004 |
Characterization of new estrogen receptor destabilizing compounds: effects on estrogen-sensitive and tamoxifen-resistant breast cancer.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Administration, Oral; Animals; Antineoplastic Agents, Hormonal; Breast Neoplasms; Disease Models, Animal; Disease Progression; Drug Resistance, Neoplasm; Estradiol; Estrogen Receptor Modulators; Estrogens; Female; Humans; Injections, Subcutaneous; Methylnitrosourea; Mice; Neoplasms, Hormone-Dependent; Receptors, Estrogen; Selective Estrogen Receptor Modulators; Tamoxifen; Transplantation, Heterologous | 2004 |
Efficacy of Targretin on methylnitrosourea-induced mammary cancers: prevention and therapy dose-response curves and effects on proliferation and apoptosis.
Topics: Animals; Antineoplastic Agents; Apoptosis; Carcinogens; Cell Division; Diet; Insulin-Like Growth Factor I; Mammary Neoplasms, Experimental; Methylnitrosourea; Rats; Retinoid X Receptors; Tamoxifen | 2005 |
Effect of glibenclamide on N-nitroso-N-methylurea-induced mammary tumors in diabetic and nondiabetic rats.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Blood Glucose; Diabetes Mellitus, Experimental; Drug Interactions; Female; Glucose Tolerance Test; Glyburide; Hypoglycemic Agents; Insulin; Mammary Neoplasms, Experimental; Methylnitrosourea; Rats; Rats, Sprague-Dawley; Tamoxifen | 2005 |
Effects of liarozole fumarate (R85246) in combination with tamoxifen on N-methyl-N-nitrosourea (MNU)-induced mammary carcinoma and uterus in the rat model.
Topics: Animals; Breast Neoplasms; Cell Proliferation; Disease Models, Animal; Drug Therapy, Combination; Female; Imidazoles; Methylnitrosourea; Ovariectomy; Rats; Rats, Sprague-Dawley; Tamoxifen; Uterus | 2007 |
A novel steroidal selective steroid sulfatase inhibitor KW-2581 inhibits sulfated-estrogen dependent growth of breast cancer cells in vitro and in animal models.
Topics: Administration, Oral; Animals; Breast Neoplasms; Cell Proliferation; Coumarins; Cricetinae; Disease Models, Animal; Enzyme Inhibitors; Estradiol; Estrogen Antagonists; Estrone; Female; Gene Expression Regulation, Enzymologic; Humans; Leukocytes; Methylnitrosourea; Molecular Structure; Rats; Rats, Sprague-Dawley; Receptors, Progesterone; Signal Transduction; Steryl-Sulfatase; Sulfonamides; Sulfonic Acids; Tamoxifen; Tumor Cells, Cultured | 2007 |
Lack of efficacy of the statins atorvastatin and lovastatin in rodent mammary carcinogenesis.
Topics: Alkylating Agents; Animals; Anticarcinogenic Agents; Anticholesteremic Agents; Antineoplastic Agents, Hormonal; Apoptosis; Atorvastatin; Bexarotene; Cell Proliferation; Diet; Disease Models, Animal; Female; Genes, erbB-2; Heptanoic Acids; Lovastatin; Mammary Neoplasms, Experimental; Methylnitrosourea; Mice; Mice, Knockout; Mice, Transgenic; Pyrroles; Rats; Rats, Sprague-Dawley; Receptors, Estrogen; Retinoid X Receptors; Tamoxifen; Tetrahydronaphthalenes; Treatment Outcome; Tumor Suppressor Protein p53 | 2009 |
The impact of fish oil on the chemopreventive efficacy of tamoxifen against development of N-methyl-N-nitrosourea-induced rat mammary carcinogenesis.
Topics: Alkylating Agents; Animals; Antineoplastic Agents, Hormonal; Apoptosis; Cell Proliferation; Fatty Acids; Female; Fish Oils; Liver; Mammary Neoplasms, Experimental; Methylnitrosourea; Precancerous Conditions; Rats; Rats, Sprague-Dawley; Tamoxifen | 2010 |
Mammary gland density predicts the cancer inhibitory activity of the N-3 to N-6 ratio of dietary fat.
Topics: Adipose Tissue; Alkylating Agents; Animals; Antineoplastic Agents, Hormonal; Cytokines; Diet; Enzyme-Linked Immunosorbent Assay; Fatty Acids, Omega-3; Fatty Acids, Omega-6; Female; Insulin-Like Growth Factor I; Mammary Glands, Animal; Mammary Neoplasms, Experimental; Methylnitrosourea; Rats; Rats, Sprague-Dawley; Tamoxifen | 2011 |
Effects of fish oil and Tamoxifen on preneoplastic lesion development and biomarkers of oxidative stress in the early stages of N-methyl-N-nitrosourea-induced rat mammary carcinogenesis.
Topics: Animals; Biomarkers; Caspase 3; Cell Transformation, Neoplastic; Diet; Enzyme Activation; Fatty Acids; Female; Fish Oils; Glutathione; Glutathione Peroxidase; Ki-67 Antigen; Mammary Glands, Animal; Mammary Neoplasms, Experimental; Methylnitrosourea; Oxidative Stress; Precancerous Conditions; Rats; Rats, Sprague-Dawley; Tamoxifen; Time Factors | 2011 |
Fish oil alters tamoxifen-modulated expression of mRNAs that encode genes related to differentiation, proliferation, metastasis, and immune response in rat mammary tumors.
Topics: Animals; Cell Differentiation; Cell Proliferation; Cell Transformation, Neoplastic; Corn Oil; Dietary Fats; Female; Fish Oils; Gene Expression Regulation, Neoplastic; Immunity; Mammary Neoplasms, Experimental; Methylnitrosourea; Polymerase Chain Reaction; Rats; Reproducibility of Results; RNA, Messenger; Tamoxifen; Transcriptome | 2012 |
Proteomic changes induced by effective chemopreventive ratios of n-3:n-6 fatty acids and tamoxifen against MNU-induced mammary cancer in the rat.
Topics: Alkylating Agents; Animals; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Diet; Fatty Acids, Omega-6; Female; Mammary Neoplasms, Experimental; Methylnitrosourea; Rats; Rats, Sprague-Dawley; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Tamoxifen | 2013 |
Influence of omega-3 fatty acids on Tamoxifen-induced suppression of rat mammary carcinogenesis.
Topics: Animals; Antineoplastic Agents; Biomarkers, Tumor; Carcinogenesis; Chemoprevention; Diet; Fatty Acids, Omega-3; Female; Fish Oils; Ki-67 Antigen; Mammary Glands, Animal; Mammary Neoplasms, Experimental; Methylnitrosourea; Precancerous Conditions; Rats; Rats, Sprague-Dawley; Tamoxifen | 2014 |
Correlation of tumour response with starting tumour size and dose of tamoxifen in an N-methyl-N-nitrosourea (NMU)-induced rat mammary cancer model.
Topics: Animals; Body Weight; Creatinine; Drug Dosage Calculations; Female; Mammary Neoplasms, Experimental; Methylnitrosourea; Random Allocation; Rats; Rats, Sprague-Dawley; Tamoxifen; Treatment Outcome; Tumor Burden; Urea | 2014 |
The phytoestrogenic Cyclopia extract, SM6Met, increases median tumor free survival and reduces tumor mass and volume in chemically induced rat mammary gland carcinogenesis.
Topics: Animals; Antineoplastic Agents, Phytogenic; Cell Line, Tumor; Cyclopia Plant; Estrogen Antagonists; Female; G1 Phase Cell Cycle Checkpoints; Humans; Mammary Glands, Animal; Mammary Neoplasms, Experimental; Methylnitrosourea; Phytoestrogens; Rats; Receptors, Estrogen; Survival Analysis; Tamoxifen; Tumor Burden | 2016 |
Modulating SIRT1 activity variously affects thymic lymphoma development in mice.
Topics: Adenocarcinoma of Lung; Administration, Oral; Animals; Antineoplastic Agents, Hormonal; Carcinogenesis; Gene Expression Regulation, Neoplastic; Lymphoma, T-Cell; Male; Methylnitrosourea; Mice; Mice, Inbred C57BL; Mice, Transgenic; Oncogene Proteins, Fusion; Organ Specificity; Protein-Tyrosine Kinases; Signal Transduction; Sirtuin 1; Survival Analysis; Tamoxifen; Thymus Gland; Thymus Neoplasms; Transfection | 2018 |
Effect of Voacamine upon inhibition of hypoxia induced fatty acid synthesis in a rat model of methyln-nitrosourea induced mammary gland carcinoma.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Body Weight; Carcinoma; Computer Simulation; Electrocardiography; Fatty Acids; Female; Heart Rate; Hypoxia-Inducible Factor-Proline Dioxygenases; Ibogaine; Mammary Glands, Animal; Mammary Neoplasms, Experimental; Metabolome; Methylnitrosourea; Neovascularization, Pathologic; Rats, Wistar; Tamoxifen | 2021 |